
Interpace Diagnostics (IDXG) P/E Ratio
P/E Ratio as of Aug 31, 2026: 1.72
Average1.79
Median1.81
Minimum1.61
Maximum1.93
1.72
0.00 (0.00%)past month
The P/E ratio for Interpace Diagnostics (IDXG) is 1.72 as of Aug 31, 2026. This represents a decrease of -29.51% compared to its 12-month average P/E ratio of 2.44. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Interpace Diagnostics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Interpace Diagnostics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Interpace Diagnostics to industry peers.
Interpace Diagnostics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Interpace Diagnostics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Interpace Diagnostics to industry peers.
Interpace Diagnostics (IDXG) P/E Ratio Insights
See Interpace Diagnostics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Interpace Diagnostics (IDXG)
Order type
Buy in
Order amount
Est. shares
0 shares
Interpace Diagnostics (IDXG) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Aug 3, 2026 | $7.95 | 1.80 |
| Jul 1, 2026 | $8.05 | 1.82 |
| Jun 1, 2026 | $8.60 | 2.35 |
| May 1, 2026 | $10.60 | 2.90 |
| Apr 1, 2026 | $9.25 | 2.53 |
| Mar 2, 2026 | $9.05 | 2.36 |
| Feb 2, 2026 | $8.535 | 2.23 |
| Jan 2, 2026 | $5.95 | 1.55 |
Interpace Diagnostics (IDXG) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | 1.72 | +6.83% |
| 2025 | 1.61 | -29.07% |
| 2024 | 2.27 | -181.07% |
| 2023 | -2.80 | +1,455.56% |
| 2022 | -0.18 | -91.30% |
| 2021 | -2.07 | — |
FAQs About Interpace Diagnostics (IDXG) P/E ratio
The latest P/E ratio of Interpace Diagnostics (IDXG) is 1.72, as of Aug 31, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Interpace Diagnostics’s last 12-month average P/E ratio is 2.44, compared to its current P/E ratio of 1.72. This reflects a decrease of -29.51%.
Interpace Diagnostics’s current P/E ratio of 1.72 is lower than its last 12-month average P/E of 2.44. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Interpace Diagnostics’s average P/E ratio over the last 3 years is 2.25. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Interpace Diagnostics’s average P/E ratio over the last 5 years is 0.99. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.